I.H.J.T. De Hingh

Scarton, A., Kerkhoff, T. M. E., van Erning, F. N., Burger, J. W. A., Sommariva, A., & de Hingh, I. H. J. T. (2026). Conversion surgery after repeated intraperitoneal chemotherapy in unresectable peritoneal metastatic colorectal cancer: a narrative review of the literature. European Journal of Surgical Oncology, 52(6), Article 111803. https://doi.org/10.1016/j.ejso.2026.111803

De Wilde, A. J., De Jong, E. J. M., Bruno, M. J., Besselink, M. G., Van Der Geest, L. G. M., Geurts, S. M. E., Groot Koerkamp, B., De Hingh, I. H. J. T., De Meijer, V. E., Miclea, R. L., Poley, J. W., Samarska, I. V., Van Santvoort, H. C., Stommel, M. W. J., Voermans, R. P., Olde Damink, S. W. M., De Vos-Geelen, J., & Bouwense, S. A. W. (2026). Population-Based Cohort Study on Treatment and Overall Survival of Patients Clinically Diagnosed With T1 Ampullary Cancer. Annals of Surgery, 283(6), 1060-1067. https://doi.org/10.1097/SLA.0000000000006563

Schouten, T. J., Prinsze, K. J., Henry, A. C., Daamen, L. A., Besselink, M. G., Bonsing, B. A., Bosscha, K., Busch, O. R., Cirkel, G. A., van Dam, R. M., van Eijck, C. H., Festen, S., Koerkamp, B. G., van der Harst, E., de Hingh, I. H. J. T., Kazemier, G., Liem, M. S. L., de Meijer, V. E., Mieog, J. S. D., ... Dutch Pancreatic Canc Grp (2026). Long-term oncological outcomes following algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection: a post-hoc analysis of a nationwide, stepped-wedge cluster-randomised trial. The Lancet Gastroenterology and Hepatology, 11(4), 323-333. https://doi.org/10.1016/S2468-1253(25)00367-X

Van Den Heuvel, T. B. M., Rauwerdink, P., Hulshof, E., Van De Vlasakker, V. C. J., Moes, D. J. A. R., Pluimakers, G., Rovers, K. P. B., Creemers, G.-J., Burger, P. J. W. A., Nienhuijs, S. W., Wiezer, R. J., Lurvink, R. J., Boerma, D., De Hingh, I. H. J. T., & Deenen, M. J. (2026). Absolute Bioavailability of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC): Systemic Pharmacokinetics of the CRC-PIPAC-II Trial. Annals of Surgical Oncology, 33(4), 3004-3017. https://doi.org/10.1245/s10434-025-18874-6

Graus, M. U. J. E., van Diepen, A. E., Broekman, T., van Eijck, C. W. F., van Hooft, J. E., Homs, M. Y. V., Wumkes, M. L., Wilmink, J. W., de Hingh, I. H. J. T., Valkenburg-van Iersel, L. B. J., van der Geest, L. G. M., & Vos-Geelen, J. D. (2026). Comparing short- and long-term survivors in metastatic pancreatic cancer: Insights into patient and disease profiles impacting systemic therapy outcomes. European Journal of Cancer, 236, Article 116263. https://doi.org/10.1016/j.ejca.2026.116263

van der Geest, L. G., van der Mark, M., Verheij, J., Farina Sarasqueta, A., de Vos-Geelen, J., Besselink, M. G., de Meijer, V. E., de Hingh, I. H. J. T., Bonsing, B. A., de Reuver, P. R., Willemssen, F. E. J. A., Vissers, P. A. J., Visser, O., & Dutch Pancreatic Cancer Group and the Dutch Hepatocellular & Cholangiocarcinoma Group (2026). Increased incidence, survival, and registration quality of primary hepato-pancreato-biliary cancers in the Netherlands Cancer Registry. International Journal of Cancer, 158(5), 1237-1249. https://doi.org/10.1002/ijc.70145

Graus, M. U. J. E., Willems, R. A. L., Biesma, N. C., de Wilde, A. J., van den Berkmortel, F. W. P. J., Bouwense, S. A. W., Cirkel, G. A., Homs, M. Y. V., Jellema-Betten, E., Pepels-Aarts, N., van Santvoort, H. C., van Vliet, E. C. J., Wumkes, M. L., Wilmink, J. W., de Hingh, I. H. J. T., Valkenburg-van Iersel, L. B. J., de Vos-Geelen, J., & Dutch Pancreatic Cancer Group (2026). Preference versus protocol: oncology clinicians’ perspectives on central venous access for administration of chemotherapy in pancreatic cancer. ESMO Gastrointestinal Oncology, 11, Article 100311. https://doi.org/10.1016/j.esmogo.2026.100311

Broekman, T. H. T., Augustinus, S., Biesma, N., Bonsing, B. A., Cirkel, G. A., de Hingh, I. H. J. T., Homs, M. Y. V., van Hooft, J. E., van der Kolk, M., de Meijer, V. E., van Santvoort, H., de Vos-Geelen, J., Wumkes, M. L., Besselink, M. G., Wilmink, J. W., van der Geest, L. G., & Dutch Pancreatic Canc Grp (2026). Regional variation for tumour-directed treatment and survival in patients with pancreatic adenocarcinoma: a nationwide population-based analysis. HPB, 28(3), 417-425. https://doi.org/10.1016/j.hpb.2025.12.035

van Erning, F. N., Galanos, L. J. K., Lurvink, R., Aarts, M. J., van Hellemond, I. E. G., Nagtegaal, I. D., de Hingh, I. H. J. T., de Wilt, J. H. W., & Elferink, M. A. G. (2026). Socioeconomic differences among patients with stage I-III colon cancer: Detection, treatment and relative survival. International Journal of Cancer, 158(5), 1262-1271. https://doi.org/10.1002/ijc.70181

Lansbergen, M. F., Smith, I. P., Van Alphen, E. N., Augustinus, S., Fransen, I. J. M., Wilmink, J. W., Besselink, M. G., Molenaar, I. Q., Homs, M. Y. V., de Hingh, I. H. J. T., Bonsing, B. A., De Vos - Geelen, J., Haberkorn, B. C. M., Vissers, P. A. J., Nieuwkerk, P. T., Bijlsma, M. F., Frederix, G. W. J., van Laarhoven, H. W. M., & Dutch Pancreatic Canc Grp (2025). Patient preferences for pancreatic cancer treatment (PERSEUS): a multicenter discrete choice experiment. Health and Quality of Life Outcomes, 23(1), Article 122. https://doi.org/10.1186/s12955-025-02440-5